Further in vivo studies confirmed the role of mutated BRAF in PTC progression through genes related to tumor invasion and metastasis [37] and demonstrated the key role of TSH signaling in BRAF-induced PTC initiation [38] and its relation to more aggressive features of BRAF(+) PTCs [39]. Here, BRAF is linked to neoplasm.